SCHEMBL8349092

SCHEMBL8349092

CCC(=O)OOS(=O)(=O)Cc1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.47
CA1 P00915 2/20 0.41
CA2 P00918 2/20 0.41
MMP1 P03956 1/20 0.41
MMP2 P08253 1/20 0.41
MMP9 P14780 1/20 0.41
MMP8 P22894 1/20 0.41
MMP13 P45452 1/20 0.41
TSHR P16473 4/20 0.40
GAA P10253 1/20 0.40
CYP2C19 P33261 1/20 0.40
PRSS1 P07477 3/20 0.40
PRSS2 P07478 3/20 0.40
PRSS3 P35030 3/20 0.40
ELANE P08246 2/20 0.40
HPGD P15428 2/20 0.40
FAAH O00519 1/20 0.40
PRTN3 P24158 1/20 0.40
CA5A P35218 1/20 0.40
CA9 Q16790 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6238332 0.84 KMT2A (0.44) KMT2ATSHRHPGD
SCHEMBL830996 0.83 KMT2A (0.50) KMT2ACA1CA2MMP1MMP2
SCHEMBL28236554 0.82 EPHX2 (0.47) KMT2AHPGDFAAH
SCHEMBL29135345 0.82 EPHX2 (0.47) KMT2AHPGDFAAH
SCHEMBL28237683 0.78 LMNA (0.53) KMT2ACA1CA2MMP1MMP2
SCHEMBL27740658 0.76 HSD11B1 (0.47) ELANESMN1; SMN2HSD11B1
SCHEMBL9776664 0.74 KMT2A (0.57) KMT2ACA1CA2MMP1MMP2
SCHEMBL29245395 0.74 KMT2A (0.57) KMT2ACA1CA2MMP1MMP2
SCHEMBL28799780 0.72 CA1 (0.51) KMT2ACA1CA2MMP1MMP2
SCHEMBL9815773 0.72 ALDH1A1 (0.50) KMT2ATSHRGAAELANEHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1999033468-A9 METHOD FOR TREATING HYPEROXIA CELL THERAPEUTICS INC (US) 1999-09-23 WO disclosed
WO-1999033468-A1 METHOD FOR TREATING HYPEROXIA CELL THERAPEUTICS, INC. (US) 1999-07-08 WO disclosed